By tracing the developments which have taken place in radiotherapy in the last one or two decades, I shall try to make some assessment of what has already been achieved and what promise is held by the future.
the other and so obtain a distributlon suitable for particular sites. A study has been made of the way in which radiation beams combine together to give a complex dose distribution, and it is now possible to obtain a three-dimensional picture of the dosage distribution throughout the whole of the treated area. Many devices have been made for accurately directing the beam of radiation and for ensuring precise repetition of the treatment. The subject has been turned from an art into a science.
But the fact remains that, however carefully the planning is done, there is no way of improving the distribution beyond a certain point set by the properties of the X-ray beam itself. Faced with this daily problem of the necessity of a good dose distribution, it was inevitable that there should have been the greatest interest by those practising radiotherapy in the use of very high voltage X-rays. In my own Unit, in which we were carrying out an investigation into the value of radium beam therapy, the rapidly falling depth dose from such apparatus kept this problem constantly before us. It should first be said that it was impracticable to develop the conventional type of X-ray apparatus for a tension of several million volts. It was not simply a matter of cost. New technical ideas were needed before such X-ray apparatus became a practical possibility.
In 1938 the Medical Research Council granted a request we made to build a 2 million volt van der %3raaff generator in order to obtain a better dose distribution within the patient than was possible with the 10-gramme radium beam apparatus which we were using for clinical work at that time. Van der Graaff machines did not become commercially available until many years later. The construction of this high voltage generator progressed very slowly during the war years and, by the time it was completed in 1944, work in the U.S.A. on super-voltage X-ray machines had resulted in the construction of a betatron producing X-rays at a much higher voltage than 2 MeV. Weidecided, therefore, to wait for apparatus having all the technical advances which could be foreseen before starting a trial of super-voltage therapy. For this and also for an even more important reason, to which I will refer later, we decided not to use our 2 MeV generator in 1944 for the treatment of patients, as was originally intended, but to use it as a source of radiation for radiobiological studies. Serious consideration was given by members of the Unit at this time to obtaining a betatron and adapting it for clinical use. It became apparent that many difficulties were encountered in the operation of the betatron and in 1945 the possibility of designing a linear accelerator became evident.
There was a sudden surge of interest in the decade 1940/1950 in the production and use of higher voltages and physicists and engineers developed the specialized techniques that were needed. As often happens, several ideas originated simultaneously in different parts of the world and these have resulted in the production of a variety of supervoltage X-ray machines. The arrival of the betatron, the synchrotron and the linear accelerator is in itself a full and fascinating story. They were first built for nuclear physics, but measurements of the high-voltage X-rays produced by them showed that they could offer much to the radiotherapist. Our knowledge of the physical characteristics of the higher energy radiations was rapidly enlarged when in 1943 depth dose curves for 4, 10 and 20 million volt X-rays were published. It was evident that radiation in this energy range gave a vastly improved dose distribution in the treatment of all but superficial tumours. This improvement made possible the treatment of even the most deeply seated tumours without any skin reaction.
A very lively interest was taken in these developments and it was hoped that these large and expensive machines could soon be brought into hospitals to give the much-needed improvement in treatment technique. The needs of a nuclear physicist, however, for a laboratory machine in which a certain amount of temperament is excusable are very different from those of a radiotherapist working to a carefully planned schedule of treatment.
Very soon the variety of machines became so wide that it was a matter of some difficulty to choose between them. Among the first in the field was the compact 2 MeV van der Graaff machine, developed far beyond its state in 1939. It is now commercially available from the U.S.A. in a form suitable for clinical use, and three of these machines are installed in hospitals in this country. Two 30 MeV synchrotrons financed by the M.R.C. have also been installed in this country. UJnless some means can be found, however, of increasing their low output they are not very suitable for the treatment of any large number of cases. Since 1945 we had taken a keen interest in the possibility of using the new techniques for accelerating electrons and we collaborated closely with other groups in this country then interested in these ideas. Some two years later the 3.5 MeV travelling wave linear accelerator was brought into operation by the A.E.R.E. group working at T.R.E. Malvern. The successful operation of this machine at a high X-ray intensity at once made possible the development of a machine for clinical use, and this project was supported by the M.R.C. It has been the experience in many parts of the world that from the time a machine is working satisfactorily in the laboratory about four years' work is necessary to re-build it as a clinical machine ready for installation in a hospital. This is about the time taken with the M.R.C. linear accelerator, which has recently been completed and installed. It is a fixed machine but the X-ray beam can be angulated through 120°, and to obtain a vertical movement for positioning the patient the whole floor of the treatment room can be moved up and down over a distance of 5 feet. It is suspended from the ceiling, leaving the floor clear. This machine has a stabilized output of 100 to 200 r per minute at an energy of 8 MeV at an f.s.d. of 1 metre, a performance which is entirely satisfactory.
The extension of the principles used in the M.R.C. linear accelerator led to the design of a very compact and mobile 4 MeV machine. Much useful information has been gained during the construction of the M.R.C. machine which has helped in the final design of the 4 MeV linear accelerator. This design was accepted by the Ministry of Health, and five such machines are being constructed, the first of which is now nearly ready for test.
The development of the high flux heavy water pile at Chalk River, Canada, has made possible the production of radioactive cobalt sources of such intensity and compactness that they can be used for telecurie units working at a focus skin distance of 70 cm. The dose distribution from such apparatus is comparable with that of a 2 MeV X-ray machine. This opens up new possibilities for the provision of a penetrating radiation from a relatively simple apparatus. The complexity here, however, lies in the pile itself which is used for the activation of the cobalt. It is at present somewhat uncertain how many such sources can be activated with the necessary high activity from one pile.
There is little doubt that we are only at the beginning of a supervoltage era. Large and expensive though supervoltage equipment is, the high cost is to a great extent offset by the much greater number of patients it is possible to treat on such a machine, as compared with the routine 200 kV apparatus.
It is hoped that with facilities for treatment by many millions of volts, we shall be able to deliver and control the dose to the tumour with the same precision and ease previously only possible for superficial tumours. One advantage which is certain is that the patient can be treated with a much greater degree of comfort. The reduction in skin reaction itself is a major contribution to the value of X-ray therapy and it can be safely assumed that the lower energy absorption in bone will also lessen the risk of bone necrosis and so contribute to the success of treatment.
The aim of all the technical advances I have just described has been to ensure that the whole tumour shall receive an adequate dose of radiation with a minimum amount of damage to surrounding normal tissues. With the advent of radioactive isotopes came the hope that this same end might be attained by chemical means in that some radioactive element or compound might be selectively concentrated in tumour tissue.
If the tumour dose is of the order of 6,000 r and the permissible dose to the whole of the body no more than 300 r, then for therapy to take place by an isotope the concentration in the tumour must be at least twenty times greater than that of the average concentration in the rest of the body.
So far as malignant disease is concerned, the only therapeutic application of radioactive isotopes which has met with any real degree of success has been the treatment of some cases of carcinoma of the thyroid. The selective concentration here takesplace simply by reason of the specialized biochemical reaction which occurs in the thyroid gland involving the element iodine. Unfortunately, however, the majority of thyroid tumours are so anaplastic and undifferentiated that they have lost this specialized function and there is, in such cases, no appreciable uptake of iodine at all. Even in the differentiated tumours where iodine uptake is still retained, an important point to remember is that the treatment of cancer of the thyroid depends on the total destruction of all functional thyroid tissue, whether it be in the gland itself or in functional metastases. Since it is possible for the patient to live normally without any thyroid tissue, provided he is maintained on the appropriate hormones, this total destruction of all thyroid tissue does not matter. There are few other tissues in the body, however, whose total destruction could be tolerated. This fact considerably reduces the possible exploitation of the affinity of particular tissues for particular elements or compounds.
Apart from this, the much greater problem has to be faced of administering a radioactive material in such a form that there is not only an affinity for the particular tissue in question but also the required differential uptake between normal and malignant tissue. This involves a much greater knowledge of the metabolism of both normal and malignant tissues of various kinds than exists at present, and the most important use of radioactive isotopes is almost certainly their employment as a research tool for the biochemical studies which must be carried out before this knowledge can become available.
It is possible, to a certain extent, to overcome the difficulty of whole body radiation or the total destruction of the treated tissue by exploiting the difference in the fate of administered isotopes, dependent on their physical, as distinct from their chemical, form. An example of this is the use of isotopes in colloidal form. For instance, large particles, or gels, are trapped in the pulmonary capillaries and tend to collect in the lungs. The treatment of carcinomatosis by instillation of colloidal gold into the peritoneal cavity is well known. It is exceedingly difficult to employ these treatments on any other than a very empirical basis because of the impossibility of obtaining any reliable physical data concerming the radiation dosage received by tissue treated in this way.
Finally, there are a number of techniques where radioactive isotopes are employed as substitutes for radium and radon. Examples of this are the use of cobalt wire instead of radium needles and the use of solutions or gases in balloons in intracavitary radiation and, of course, the use I have already mentioned, of radioactive cobalt instead of radium in telecurie units. There is nothing fundamentally new in these methods but they offer important practical advantages.
The use of isotopes for the treatment of certain non-malignant conditions is much more promising at present, because the aim here is to affect function rather than to achieve total destruction, so that the requirements with regard to selective concentration are not nearly so stringent as is the case in malignant disease. Moreover, in such examples as thyrotoxicosis and polycythlmia, the target tissue, in this case the thyroid and the bone-marrow, as a direct consequence of the disease which is being treated, has a greatly increased affinity for the isotope. It is probable that a greater knowledge of the physiology and response to radiation of the various types of tissue gained by using isotopes as tracers will lead to the discovery of other therapeutic applications of this type.
The following are a few interesting examples of the applications which have been made of isotopes to general medical problems. Radioactive sodium has been used to develop a method of comparing the placental blood flow in normal and hypertensive patients. It has been demonstrated that the placental ischemia which was thought to occur in pre-eclamptic patients did, in fact, exist, in that the placental blood flow was only about one-third of that in normal women. In addition, it has been shown that the same degree of placental ischoemia occurs in patients with chronic hypertension, indicating that the hypertension is probably a cause rather than a result of the reduced placental blood flow. Arising out of this work, it became necessary to devise a simple technique for the localization of the placental site and a method, using radioactive sodium, is being developed which makes possible the diagnosis of placenta previa with an accuracy equal to that obtainable by X-ray diagnostic methods.
The local tissue clearance of radioactive sodium has been applied to tubed skin pedicles, initially to meet the need of a reliable diagnostic test which would enable the plastic surgeons to assess the circulation in a skin graft before its transfer. The availability of a quantitative test, however, has made possible the scientific study of many of the practical problems arising in skin-grafting operations. It is now possible to carry out such procedures with fewer operations and with a substantially reduced period of stay in hospital for the patient. By the use of radioactive phosphorus a simple yet accurate method has been developed for measuring the circulating red cell volume. The availability of this method has enabled much information to be obtained on red cell and plasma volume in newborn infants for which no reliable data had previously existed. It has also enabled red cell volume measurements to be carried out for evaluating the result of isotope therapy in polycythaemia; these blood volumes have been found to differ materially from those anticipated by indirect methods.
The tracer applications of radioactive iodine in the assessment of thyroid function are well known. These are just a few examples of the use which has been made of radioactive isotopes in tracer investigations. Many tentative proposals await investigation when short-lived isotopes become available from the M.R.C. cyclotron.
I have attempted to trace the development of the great advances which have been made in radiotherapeutic technique over the past one or two decades. I would like now to consider just what has been achieved by these advances in technique. The first question that one naturally wants to answer is whether these great advances in technique have resulted in any correspondingly great improvement in the cure rate of cancer. When in 1945 we made a comparison of the clinical results obtained in the Unit in more recent years in the treatment of cancer of the mouth and throat with those obtained more than ten years previously, it became clear that the great advances which had been made in the technique of treatment in the intervening years had not resulted in any correspondingly large increase in the proportion of patients cured. It appeared that further improvement in the distribution and control of dosage were not the only matters, nor even the most important, which should be considered in future research in radiotherapy.
It was thought possible at one time that supervoltage X-radiation might have a different biological effect from that of 200 kV X-rays. If this were so then supervoltage therapy would mean something more than a purely technical advance. In order to get an answer to this question we carried out in the Unit a clinical experiment to compare the results obtained by using 200 kV and the gamma rays of radium which are equivalent approximately to X-rays produced at about 2 MeV. In the experiment two series of patients were treated, one with an X-ray beam and one with a gamma ray beam, and every effort was made to eliminate variables in the two series of patients treated. The results of this investigation did not show that the wavelength of radiation per se within the limits of the experiment, i.e. 200 kV and approximately 2 MeV, had any significant effect on the clinical results. We therefore concluded from our experiment that the great advantage to be expected from the use of supervoltage therapy was not in any different biological effect, but in the enormously improved dosage distribution which could be obtained by this means. The advance is a purely technical one resulting in a better dose distribution. Although we can be sure, as I have already mentioned, that it will be possible to treat patients with a much greater degree of comfort, we have, I think, no reason to believe that there will be any spectacular improvement in cure rate by the use of the technical advances inherent in supervoltage therapy.
The comparison of cure rates obtained at different centres is extremely difficult due to a lack of uniformity in the presentation of results. There is also a lack of published figures for many sites treated because so many centres only publish the results of special series of cases and not the results of all their work. This fact is internationally recognized as an outstanding problem and it is to be hoped that, in the near future, great improvement will occur in the presentation and analysis of results of the treatment of cancer.
So much valuable information could be gained from the clinical work which is in progress in so many centres, if work could be based to a much greater extent than it is at present on making definite comparisons between different methods of treatment and getting a decisive answer. Clinical experiments are often more difficult than laboratory experiments. The classical method of clinical research was that of observing the individual patient's reaction to treatment and drawing conclusions from the reactions found to be common in relatively small groups of patients. The modern method tends to be the simultaneous comparison of alternative treatments applied to properly randomized groups of patients. The simultaneous trial of two alternative treatments is a much more satisfactory procedure than the comparison of a new treatment with results obtained in an earlier period or in another institution. Much progress could be made in clinical radiotherapy if there were planned experiments of this type. We ought to look forward to even greater co-operation with our surgical colleagues and be prepared to make comparisons between the results of surgery and radiotherapy by means of planned experiments: for example, in the simplest case, by arranging for patients who have been assessed as operable, to be allocated objectively either to surgery or radiotherapy as the primary means of attack. We should, by this means, finally get a decisive answer to many questions which have been debated over a long period of years.
In Fig. 1 the results of treatment of some 1,748 cases of carcinoma of the laryngo-pharynx are shown. These cases were treated at different centres in this and other countries by many different methods. The outstanding fact revealed by a study of these figures is that in no centre are results obtained in which there is a significant difference from any other centre or from the overall result. It seems reasonable to conclude that some factor in the tumour itself, a factor of which unhappily we are at present ignorant, has a far greater influence on the final prognosis than the particular form or technique of treatment employed. FIG. 1. -The percentage five-year survival rates' of different groups of cancer of the laryngo-pharynx and post-cricoid cancer are shown with the confidence limits for each group. The percentage survival rate is indicated by the small thick black vertical line and the confidence limits for each group are represented by the horizontal lozenge. These confidence limits are seen to vary in length according to the number of patients in each group-the larger the number of cases the nearer do the confidence limits approach the estimated survival rates.
ANALYSIS OF
We may well doubt whether all the efforts which have gone into making great technical improvements in radiotherapy have yielded a commensurate return.
While the percentage cure rates show little change it is well to remember that accurate dosimetry and beam direction make it possible for treatment to be given to large numbers of patients in accordance with techniques based on the observation and experience of the most reliable radiotherapists.
Thus, even if we do no more than hold the percentage cure rate constant, the number of individuals cured of their disease will rise year by year in proportion to the number treated, so that in terms of human lives something worth while may be said to have been accomplished. 'Note.-When a limited number of patients has been treated, the five-year survival rate for such a group does not enable us to say with certainty what the survival rate would be if a much larger group of patients were treated-that is to say, what is the true survival rate for the method of treatment. Knowing the number of patients treated and their five-year survival rate, however, from elementary statistical theory one can quote limits between which the true value will lie in most cases. We wish to keep the limits as close as possible in order to detect small differences between methods of treatment and we must therefore adopt by convention some "measure of confidence". If we accept limits within which the true value should lie in 19 cases out of 20, we shall be following ordinary statistical practice. Such confidence limits are indicated by the length of the black lozenge in the diagram.
The treatment has been made measurable and repeatable. This accurate dosimetry and beam direction have been indispensable in enabling us to make comparisons; for instance it has been shown, at least as regards the oral cavity, that when treated with the same dosage, the radiocurability of primary tumour and metastases is similar. Again comparing the response of two tumours to the same treatment we have been able to show that two tumours of apparently identical histology and similar clinical appearance may respond quite differently to the same treatment. It is only as a result of making the physical aspects of radiotherapy quantitative that it is possible to assert that we are really up against a biological problem and can make some statement about the elements of this problem.
Further progress in radiotherapy is most likely to come from a better understanding of the mode of action of radiation on the body.
A study of the general metabolic effects produced in patients by radiation presents considerable difficulties. When we study the effect of radiation on one system within the body, for example the extracellular fluid, the problems of interpretation become very complex indeed. It is virtually impossible to separate out what may correctly be regarded as radiation damage from the response of the whole body to that damage. Nevertheless, a study of the whole body response of patients has recently yielded most interesting results. It has been shown that a response as complex as radiation sickness can be studied in a quantitative manner and when this is done interesting correlations are revealed between the response, the dose and the size of the patient. These point to likely sites of origin of the initial disturbance and so carry the investigation to further levels. Considerable progress has been made in the study of cell metabolism and research in this field has yielded much valuable information. Tracer doses of radioactive isotopes have been combined with microscopical observations to study the dynamics of metabolism of irradiated tissue by the autoradiograph technique. As yet the gap between this type of research and clinical practice has not been bridged. It is, I think, fair to say that so far it has not proved possible to make any clinical application of the knowledge gained with a consequent improvement in cure rate. Several milestones, however, have been passed. It has been recognized that the biological response to a given dose may be correlated, except in very rare instances, with the spacing of the ions along the tracks of the ionizing particles. This has re-emphasized the fact that there is no great difference in biological efficiency between 200 kV X-rays and those generated at much higher voltages. It has, however, indicated that the biological efficiency of neutrons relative to X-rays is greater by a factor of between 5 and 10. Whether the radiobiological difference between neutrons and X-rays can be made advantageous to the therapist or the reverse, is for a clinical trial to determine. The one clinical trial which has already been carried out in the U.S.A. clearly suffered from a lack of good neutron dosimetry at that time.
Our physical ideas about the distribution of ions along particle tracks have advanced hand in hand with an experimental study of the chemical effects of different types of radiation. Very valuable work has been done in radiation chemistry and physical reasons for the very marked difference between the characteristics of chemical changes produced by high voltage X-rays on the one hand and neutron and alpha particles on the other hand, are now apparent. Ever increasing knowledge is accruing which emphasizes the importance of radiation chemistry as a link between the original ionization and the eventual biological response not only in a part of the organism but in the organism as a whole.
It has been known for some time that the effectiveness of a dose of radiation is modified by the amount of dissolved oxygen present. Recently, this effect has been studied both in plant tissues and mammalian tissues and the same effect has been shown in all the tissues so far investigated. If dissolved oxygen is present in the tissue at the time-of radiation, the biological efficiency of the radiation is about two and a half times greater than when oxygen is not present. It may be concluded, therefore, that dissolved oxygen plays a part in handing on the energy of radiation to the living cell. The importance of this knowledge lies in the fact that it may lead to our being able to understand, and possibly control, for the first time an intermediate step in the action of X-rays. It may even be possible to utilize this knowledge in clinical practice, the prospect of success depending on the existence of a differential effect between normal and malignant tissue. As our knowledge extends, a further variable may be given to the radiotherapist, which may enable him to influence the biological efficiency of radiation.
It is indeed a dynamic position in which we find ourselves to-day-with a constant interlinking and exchange of ideas between workers studying radiation effects from so many different viewpoints; the chemical effects, the effects on cell metabolism and finally the whole body response to radiation-a state of affairs which is full of possibilities.
The dream of the radiotherapist in former decades of obtaining an X-ray beam which would deliver a high dose to deep-seated tumours without damaging the skin has now been achieved. With this, however, has come the realization that improved technique will not materially increase the cure rate of cancer.
The dream of the radiotherapist to-day is that we may find ways of influencing the biological response of tissues to radiation and that it is in the realization of this hope that future progress in the next decade is most likely to be achieved.
"For each age is a dream that is dying, Or a dream that is coming to birth." -A. W. O'Shaughnessy.
